![Philippe Lopes-Fernandes](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Philippe Lopes-Fernandes
Corporate Officer/Principal chez
IPSEN
Profil
Philippe Lopes-Fernandes is currently Director at Histide AG, Chief Business Officer & Executive Vice President at Ipsen SA since 2020, and Industry Advisor at Agent Capital LLC.
Formerly, Mr. Lopes-Fernandes was Director at Bakx Therapeutics, Inc. and SVP & Head-Business Development at Merck KGaA. Education includes an undergraduate degree from Institut Supérieur de Gestion, conferred in 1994.
Postes actifs de Philippe Lopes-Fernandes
| Sociétés | Poste | Début |
|---|---|---|
| IPSEN | Corporate Officer/Principal | 01/10/2020 |
Histide AG
 Histide AG Internet Software/ServicesTechnology Services Operates as a biotech intellectual property platform for non-mutagenic extracellular therapeutic agents | Directeur/Membre du Conseil | - |
Agent Capital LLC
 Agent Capital LLC Investment ManagersFinance Agent Capital invests in companies located in the United States. The firm targets companies operating in the fields of therapeutics sectors and industries. It provides financing for seed, early, late stage, crossover and PIPE stage requirements. The firm acts as a lead investor and also makes co-investments. | Consultant / Advisor | - |
Anciens postes connus de Philippe Lopes-Fernandes
| Sociétés | Poste | Fin |
|---|---|---|
Bakx Therapeutics, Inc.
 Bakx Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel cancer therapeutics | Directeur/Membre du Conseil | - |
| MERCK KGAA | Corporate Officer/Principal | - |
Formation de Philippe Lopes-Fernandes
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
35
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Merck KGaA
 Merck KGaA Pharmaceuticals: MajorHealth Technology Engages in the manufacturing of pharmaceutical and chemical products | Health Technology |
Ipsen SA
 Ipsen SA Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Institut Supérieur de Gestion
 Institut Supérieur de Gestion Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Agent Capital LLC
Agent Capital LLC Investment ManagersFinance Agent Capital invests in companies located in the United States. The firm targets companies operating in the fields of therapeutics sectors and industries. It provides financing for seed, early, late stage, crossover and PIPE stage requirements. The firm acts as a lead investor and also makes co-investments. | Finance |
Histide AG
Histide AG Internet Software/ServicesTechnology Services Operates as a biotech intellectual property platform for non-mutagenic extracellular therapeutic agents | Technology Services |
Bakx Therapeutics, Inc.
Bakx Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel cancer therapeutics | Health Technology |
